Promoting mechanism of enhancers and transport pathway of large hydrophilic molecular across nasal epithelium studied by ESR and CLSM technologies

Yaoxue Xuebao

Volumn 42, Issue 11, 2007, Pages 1195-1200

  ZHANG, Yu Jie ^a   Zhang, Qiang ^b   Yang, Jie ^a   Sun, Ming Jie ^c   Wang, Xiao Liang ^a   Chen, Ming Xia ^a   Wang, Qi ^a   Jiang, Hao ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Absorption enhancer; Absorption promoting, mechanism; Confocal laser scanning microscopy; Electron spin resonance; Large hydrophilic molecular; Nasal epithelium; Transport pathway

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; CHITOSAN; GLYCYRRHIZIC ACID; HIRUDIN DERIVATIVE; HIRUDIN HV2; RECOMBINANT PROTEIN;

ABSORPTION; ANIMAL; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD; CONFOCAL MICROSCOPY; DRUG EFFECT; ELECTRON SPIN RESONANCE; INTRANASAL DRUG ADMINISTRATION; MALE; METABOLISM; NOSE CAVITY; NOSE MUCOSA; RABBIT; RAT; SPRAGUE DAWLEY RAT; TRANSPORT AT THE CELLULAR LEVEL;

ABSORPTION; ADMINISTRATION, INTRANASAL; ANIMALS; AREA UNDER CURVE; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CHITOSAN; ELECTRON SPIN RESONANCE SPECTROSCOPY; GLYCYRRHIZIC ACID; HIRUDINS; MALE; MICROSCOPY, CONFOCAL; NASAL CAVITY; NASAL MUCOSA; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 37549060388     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Davis SS, Illum L. Absorption enhancers for nasal drug delivery [J]. Clin Pharmacokinet, 2003, 42: 1107-1128.
2. Talley JD. Cardiology commentary and update: hirudin [J]. J Arkansas Med Soc , 1995,91:445-446.
3. Zhang YJ, Zhang Q, Hou JL, et al. The pharmacokineties and pharmacodynamics of recombinant hirudin-2 nasal spray [J]. Acta Pharm Sin, 2006,41:268-271.
4. Zhang YJ, Ma CH, Lu WL, et al. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo [J]. Acta Pharmacol Sin, 2005,26:1402-1408.
5. Chandlerr SG, Ilium L, Tomas NM. Nasal absorption in rats. II Effect of enhancers on insulin absorption and nasal histology [J]. Int J Pharm, 1991,76:61-70.
6. Griessbach U, Sturzebecber J, Markward TF. Assay of hirudin in plasma using a chromogenic thrombin substrate [J]. Thromb Res, 1985,37:347-350.
7. Tang HT, Chen YL, Shen HX, et al. Early cardiac myocyte membrane changes in severely burned rats: a spin labding-esr study [J] . Chin J Plast Surg Burns, 1999,15:224-227.
8. Hopkins AM, Walsh SV, Verkade P, et al. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function [J]. J Cell Sci, 2003,15:725-742.
9. Marttine, Verhoef JC, Spies F, et al. The effect of methylated β-cyclodextrins on the tight junctions of the rat asal respiratory epithelium: electron microscopic and confocal laser scanning microscopic visulization studies [J]. J Control Release, 1999,57:205-213.
10. Hurni MA, Noach ABJ, Blom-roosemalen MCM, et al. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport route by confocal laser scanning microscopy [J]. J Pharm Exp Ther, 1993,267:942-950.
11. Schipper NG, Olsson S, Hoogstraate JA, et al. Chitosan as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement [J]. Pharm Res, 1997,14:923-929.
12. Marttin E, Verhoef JC, Cullander C, et al. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancer [J]. Pharm Res, 1997,14:631-637.
13. Yang T, Hussain A, Paulson J, et al. Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies [J]. Pharm Res, 2004,21:1127-1136.